Research Article

Efficacy of topical clobetasol propionate in the treatment of idiopathic granulomatous mastitis

Volume: 31 Number: 3 October 31, 2018
  • Züleyha Yazıcı Özgen *
  • Elif Cömert
  • Mustafa Ümit Uğurlu
EN TR

Efficacy of topical clobetasol propionate in the treatment of idiopathic granulomatous mastitis

Abstract

Objectives: To evaluate the efficacy of topical clobetasol
propionate 0.05% pomade in the treatment of idiopathic
granulomatous mastitis.
Patients and Methods: Twenty-one idiopathic granulomatous
mastitis patients’ clinical and histopathological findings were
retrospectively reviewed. Those patients excluded from other
etiologies were categorized as idiopathic granulomatous mastitis
and treated with topical clobetasol propionate 0.05% pomade as
an initial treatment.
Results: All 21 patients with a final diagnosis of idiopathic
granulomatous mastitis were women with the average age of
36.2+/-5.2 years. Of the 21 patients; erythema, induration and pain
problems of 6 (28.5%) patients totally resolved without recurrence
in 3 months follow-up period. Erythema, induration and pain
problems of 7 (33.5%) patients were minimalized and stay stable
in 3 months follow-up period. The symptoms of 8 (38%) did not
change under topical clobetasol propionate treatment. None of the
patients developed side or adverse effects due to topical steroid
treatment and 6 of 18 patients with non-steroidal anti-inflammatory
drugs (NSAIDs) complained of gastric pain.
Conclusion:Topical steroid treatment is a safe treatment option
for idiopathic granulomatous mastitis patients before systemic
steroid and immunosuppressive treatments and also surgery.

Keywords

References

  1. 1. Baslaim MM, Khayat HA, Al-Amoudi SA. Idiopathic granulomatous mastitis: a heterogenous disease with variable clinical presentations. World J Surg 2007; 31:1677-81. doi: 10.1007/s00268-007-9116-1
  2. 2. Ocal K, Dag A, Turkmenoglu O, et al. Granulomatous mastitis: Clinical, pathological features and management. Breast J 2010; 16: 176-82. doi: 10.1111/j.1524-4741.2009.00879.x
  3. 3. Yılmaz TU, Gürel B, Güler SA, et al. Scoring idiopathic granulomatous mastitis: an effective system for predicting recurrence? Eur J Breast Health 2018; 14:112-16. doi: 10.5152/ejbh.2018.3709
  4. 4. Benson JR, Dumitru D. Idiopathic granulomatous mastitis: presentation, investigation and management. Future Oncol 2016;12: 1381-94. doi: 10.2217/fon-2015-0038
  5. 5. Al-khaaf B, Knox F, Bundred NJ. Idiopathic granulomatous mastitis: a 25-year experince. J Am Coll Surg 2008; 206: 269-73. doi: 10.1016/j.jamcollsurg.2007.07.041
  6. 6. Azlina AF, Ariza Z, Arni T, et al. Chronic granulomatous mastitis: diagnostic and therapeutic considerations. World J Surg 2003; 27: 515 – 18. doi: 10.1007/s00268-003-6806-1
  7. 7. Moris D, Damaskos C, Davakis S, et al. Is idiopathic granulomatous mastitis a surgical disease? The jury is still out. Ann Transl Med 2017;5:309-13. doi: 10.21037/ atm.2017.05.24
  8. 8. Kieffer P, Dukic R, Huiber M, et al. A young woman with granulomatous mastitis: a corynebacteria may be involved in the pathogenesis of this disease. Rev Med Intern 2006; 27: 550-4. doi: 10.1016/j.revmed.2006.03.033

Details

Primary Language

English

Subjects

-

Journal Section

Research Article

Authors

Züleyha Yazıcı Özgen * This is me
Türkiye

Elif Cömert This is me

Mustafa Ümit Uğurlu This is me
Türkiye

Publication Date

October 31, 2018

Submission Date

July 27, 2018

Acceptance Date

September 8, 2018

Published in Issue

Year 2018 Volume: 31 Number: 3

APA
Yazıcı Özgen, Z., Cömert, E., & Uğurlu, M. Ü. (2018). Efficacy of topical clobetasol propionate in the treatment of idiopathic granulomatous mastitis. Marmara Medical Journal, 31(3), 108-111. https://doi.org/10.5472/marumj.474170
AMA
1.Yazıcı Özgen Z, Cömert E, Uğurlu MÜ. Efficacy of topical clobetasol propionate in the treatment of idiopathic granulomatous mastitis. Marmara Med J. 2018;31(3):108-111. doi:10.5472/marumj.474170
Chicago
Yazıcı Özgen, Züleyha, Elif Cömert, and Mustafa Ümit Uğurlu. 2018. “Efficacy of Topical Clobetasol Propionate in the Treatment of Idiopathic Granulomatous Mastitis”. Marmara Medical Journal 31 (3): 108-11. https://doi.org/10.5472/marumj.474170.
EndNote
Yazıcı Özgen Z, Cömert E, Uğurlu MÜ (October 1, 2018) Efficacy of topical clobetasol propionate in the treatment of idiopathic granulomatous mastitis. Marmara Medical Journal 31 3 108–111.
IEEE
[1]Z. Yazıcı Özgen, E. Cömert, and M. Ü. Uğurlu, “Efficacy of topical clobetasol propionate in the treatment of idiopathic granulomatous mastitis”, Marmara Med J, vol. 31, no. 3, pp. 108–111, Oct. 2018, doi: 10.5472/marumj.474170.
ISNAD
Yazıcı Özgen, Züleyha - Cömert, Elif - Uğurlu, Mustafa Ümit. “Efficacy of Topical Clobetasol Propionate in the Treatment of Idiopathic Granulomatous Mastitis”. Marmara Medical Journal 31/3 (October 1, 2018): 108-111. https://doi.org/10.5472/marumj.474170.
JAMA
1.Yazıcı Özgen Z, Cömert E, Uğurlu MÜ. Efficacy of topical clobetasol propionate in the treatment of idiopathic granulomatous mastitis. Marmara Med J. 2018;31:108–111.
MLA
Yazıcı Özgen, Züleyha, et al. “Efficacy of Topical Clobetasol Propionate in the Treatment of Idiopathic Granulomatous Mastitis”. Marmara Medical Journal, vol. 31, no. 3, Oct. 2018, pp. 108-11, doi:10.5472/marumj.474170.
Vancouver
1.Züleyha Yazıcı Özgen, Elif Cömert, Mustafa Ümit Uğurlu. Efficacy of topical clobetasol propionate in the treatment of idiopathic granulomatous mastitis. Marmara Med J. 2018 Oct. 1;31(3):108-11. doi:10.5472/marumj.474170